6 | ENDOWMENT CASE FUNDING
Why I give
Cheryl Stratos
Doug Brodman
Melanoma changed my life forever. I was diagnosed with Stage IV metastatic melanoma on November 23, 2009. Melanoma protocols had not changed for more than
My family and I first discovered the Melanoma Research Foundation when I was diagnosed with Stage 4 melanoma. Not knowing anything about the disease, we searched for answers to
15 years, with no progress toward extending life expectancy for late-stage patients. At the age of 45 the doctors gave me six months to live. I enrolled in a Phase 1 clinical trial that saved my life and changed the “why” we fight melanoma. I am dedicated to advocating for patients battling melanoma and supporting the MRF’s mission to expand treatment options and help young investigators fund research. As a Board member of the MRF I know the importance of giving back now and planning a gift for the future. We are gaining ground in the fight against melanoma, but we need to continue to move the needle forward today and tomorrow. That is why I contribute annually and included the MRF to my estate plans to support its endowment so that the progress that has been made does not stop until we find a cure.
our many questions. The MRF website proved to be an invaluable tool, providing us with information and support throughout every stage from diagnosis, to treatment, to survivorship. Our family contributes to the MRF so we can carry on with the important work for the melanoma community through research, education and advocacy. We believe that it will continue to help patients, caregivers and families in the way it helped us.
2020
FDA approves the first combination of checkpoint plus targeted therapy for BRAF mutant metastatic melanoma.
Made with FlippingBook Ebook Creator